FDA approves Covid-19 jabs as boosters for infants
The US Food and Drug Administration has approved the use of Moderna and Pfizer/Biontech’s coronavirus vaccines as boosters for children as young as six months old.
by marketwire, translated by catherine brett
The FDA has approved the use of Moderna and Pfizer/Biontech’s corona vaccines targeting both the original strain of Covid-19 and the Omicron variant for use as booster vaccines in children as young as six months old, Retuers reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
